News
Threads
- Are antibacterial handwashes safe? Why soap and water may be the best option. (0 Replies)
- How to print an eye cell: potential for bioprinting in a future cure for blindness (0 Replies)
- Biotechnology winners in the 2013 Presidential Green Chemistry Challenge Awards (0 Replies)
- How your pet dog may protect your children from allergies (0 Replies)
- Lung cancer ALK and ROS1 oncogenes found in CRC tumours; therapeutic implications (0 Replies)
- Coffee drinking and smoking may be protective against rare liver cancer PSC (0 Replies)
- Zebrafish embryos reveal signalling link between calcium deficiency and cancer (0 Replies)
- Flukeless: Irish scientists develop a diagnostic test kit for liver fluke (0 Replies)
- Beauty product or biological weapon? An inhibitory peptide developed for botulinum (0 Replies)
- Galderna Labs faces restructuring and staff lay-offs (0 Replies)
- Diabetes drug dapagliflozin wins support of FDA advisory committee (0 Replies)
- Genome sequencing reveals new drug candidates for rhabdomyosarcoma (0 Replies)
- Hydrogel with potential for craniofacial reconstruction (0 Replies)
- New method for scoring tumour infiltrating cells and ovarian cancer prognosis (0 Replies)
- Sucessful inheritance of transgenic material in mouse sperm (0 Replies)
- Cancer drug vorinostat shows promise in GVHD phase 1/2 trial (0 Replies)
- Avian flu virus re-emergence would present potential risk to under-50s (0 Replies)
- Hepatitis C drug sofosbuvir: FDA approval imminent but legal challenges loom (0 Replies)
- FDA Approves the First Adjuvant Based H5N1 Bird Flu Vaccine (0 Replies)
- MM-121 fails primary end-point in Phase II breast cancer trial (0 Replies)
- Nitric oxide synthase inhibitors enhance antibiotic-mediated bacterial killing (0 Replies)
- Hepatitis C drug Simeprevir wins FDA approval (0 Replies)
- Nexavar to Treat Differentiated Thyroid Cancer on FDA’s Approval (0 Replies)
- Tumour cell movement from the fruit fly (0 Replies)
- FDA Approves the New Drug OLYSIO To Fight Chronic Hepatitis C (0 Replies)
- Deadly Nipah Virus and its Key Protein Structure (0 Replies)
- Experimental RSV vaccine gives promising pre-clinical results in animals (0 Replies)
- FDA Approves the New Blood Cancer Drug- Imbruvica (0 Replies)
- 2013 Malaria Vaccine Technology Roadmap (0 Replies)
- Biotechnology and batteries: modified viruses build electrodes (0 Replies)